Integration of a clinical pharmacist practitioner–led pharmacogenomics service in a Veterans Affairs hematology/oncology clinic
American Journal of Health-System Pharmacy · 23.09.2024 · 81 (19) · e634-e639
DOI: 10.1093/ajhp/zxae122 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, online erschienen am 11.05.2024. Verfasst von Emma Dreischmeier und 6 weiteren Autor:innen. Beteiligte Einrichtung: William S. Middleton Memorial Veterans Hospital, Madison, WI, USA. Hauptthemen laut MEDLINE: Pharmacists, Pharmacogenetics, United States Department of Veterans Affairs. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Purpose
This article describes the implementation and evaluation of pharmacogenomic testing within the hematology/oncology ambulatory care clinic at the William S. Middleton Memorial Veterans Hospital in Madison, WI. Summary The Pharmacogenomic Testing for Veterans (PHASER) program provides preemptive pharmacogenomic testing for veterans nationally. Program implementation at the Madison Veterans Affairs site began in the hematology/oncology clinic with the goal of integrating the offer for pharmacogenomic testing, testing completion, and review of the results by the hematology/oncology clinical pharmacist practitioner (CPP) into current workflows to create a sustainable process for PHASER. The hematology/oncology CPP designed workflows outlining how testing would be offered to patients, how results would be reported and to whom, and how documentation would occur in the electronic medical record. Veterans are offered preemptive PHASER testing, before needing therapy requiring pharmacogenomic results. Exceptions to pharmacogenomic testing were patients with a history of liver or allogeneic hematopoietic stem cell transplantation.
Conclusion
This article provides a summary of the role of the hematology/oncology CPP in the implementation of a pharmacogenomics service and the impact on medication management in a hematology/oncology clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- William S. Middleton Memorial Veterans Hospital, Madison, WI, USA.
- William S. Middleton Memorial Veterans Hospital, Madison, WI.
- UW Carbone Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Zitieren
APA
Dreischmeier, E., Hecht, H., Crocker, E., Seckel, E., Wilcox, A., Fletcher, C., & Piccolo, J. (2024). Integration of a clinical pharmacist practitioner–led pharmacogenomics service in a Veterans Affairs hematology/oncology clinic. American Journal of Health-System Pharmacy, 81(19), e634-e639. https://doi.org/10.1093/ajhp/zxae122
Vancouver
Dreischmeier E, Hecht H, Crocker E, Seckel E, Wilcox A, Fletcher C, et al. Integration of a clinical pharmacist practitioner–led pharmacogenomics service in a Veterans Affairs hematology/oncology clinic. American Journal of Health-System Pharmacy. 2024;81(19):e634-e639. doi:10.1093/ajhp/zxae122
BibTeX
@article{Dreischmeier2024,
author = {Dreischmeier, Emma and Hecht, Hannah and Crocker, Edward and Seckel, Ellina and Wilcox, Andrew and Fletcher, Christopher and Piccolo, Jennifer},
title = {Integration of a clinical pharmacist practitioner–led pharmacogenomics service in a Veterans Affairs hematology/oncology clinic},
journal = {American Journal of Health-System Pharmacy},
year = {2024},
volume = {81},
number = {19},
pages = {e634--e639},
doi = {10.1093/ajhp/zxae122}
}
EUVIMED